Six weeks post-injection, tumor volume increased, and MAGE-A3 and cyclin A2, B1 and E1 protein levels were elevated in syngeneic tumors compared to normal murine keratinocytes and Pam 212 cells grown in vitro. The gene discussed is MAGEA3; the disease is neoplasm.